2-hydroxy-5-(α-2-fluorocyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine | 201049-75-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩并吡啶类
• 英文名称: 2-hydroxy-5-(α-2-fluorocyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
• 英文别名: 2-hydroxy-5-(a-2-fluorocyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine；1-(2-fluorocyclopropyl)-2-(2-fluorophenyl)-2-(2-hydroxy-6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)ethanone
• CAS: 201049-75-4
• 化学式: C₁₈H₁₇F₂NO₂S
• 分子量: 349.401
• InChiKey: YPEYDMRQSNZTRS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  24
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  68.8
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• MEDICINAL COMPOSITION
  申请人：DAIICHI PHARMACEUTICAL CO., LTD.

  公开号：EP1319399A1

  公开（公告）日：2003-06-18

  A pharmaceutical composition containing a drug (A), a waxy substance (B), and synthetic aluminum silicate and/or hydrous silicon dioxide (C). The invention provides a granular pharmaceutical composition suitable for providing a pharmaceutical characterized in that adhesion of granules thereof onto a granulation apparatus during granulation is minimized and caking of the granules is suppressed.

  一种药物组合物，包含药物（A）、蜡状物质（B）和合成氧化铝硅和/或水合二氧化硅（C）。该发明提供了一种颗粒状药物组合物，适用于提供一种药物，其特点在于在制粒过程中减少颗粒粘附到制粒设备上，并抑制颗粒结块。
• MEDICINAL COMPOSITIONS
  申请人：DAIICHI PHARMACEUTICAL CO., LTD.

  公开号：EP1161956A1

  公开（公告）日：2001-12-12

  The present invention relates to a granular pharmaceutical composition comprising a drug having a disagreeable taste, a wax and a sugar alcohol; a method for preparing the same; and a pharmaceutical product for oral administration, comprising the granular composition. The product excellently masks a disagreeable taste possessed by a drug and provides good sensation upon oral administration, and therefore is easily ingested by even the elderly, children, and patients suffering dysphagia. Moreover, the product is suitable for administration using tube.

  本发明涉及一种颗粒状药物组合物，该组合物由具有异味的药物、蜡和糖醇组成；一种制备该组合物的方法；以及一种包含该颗粒状组合物的口服药物。该产品能很好地掩盖药物的异味，并在口服时提供良好的感觉，因此即使是老人、儿童和吞咽困难患者也很容易摄入。此外，该产品还适合使用软管给药。
• Medicinal composition
  申请人：——

  公开号：US20040022848A1

  公开（公告）日：2004-02-05

  A pharmaceutical composition containing a drug (A), a waxy substance (B), and synthetic aluminum silicate and/or hydrous silicon dioxide (C). The invention provides a granular pharmaceutical composition suitable for providing a pharmaceutical characterized in that adhesion of granules thereof onto a granulation apparatus during granulation is minimized and caking of the granules is suppressed.

  一种含有药物（A）、蜡状物质（B）和合成硅酸铝和/或水合二氧化硅（C）的药物组合物。本发明提供了一种适用于提供药物的颗粒状药物组合物，其特点是在制粒过程中将颗粒在制粒设备上的附着减至最小，并抑制颗粒的结块。
• Pharmaceutical composition
  申请人：Nakagami Hiroaki

  公开号：US20050152975A1

  公开（公告）日：2005-07-14

  The present invention relates to a granular pharmaceutical composition comprising a drug having a disagreeable taste, a wax and a sugar alcohol; a method for preparing the same; and a pharmaceutical product for oral administration, comprising the granular composition. The product excellently masks a disagreeable taste possessed by a drug and provides good sensation upon oral administration, and therefore is easily ingested by even the elderly, children, and patients suffering dysphagia. Moreover, the product is suitable for administration using tube.

  本发明涉及一种颗粒状药物组合物，该组合物由具有异味的药物、蜡和糖醇组成；一种制备该组合物的方法；以及一种包含该颗粒状组合物的口服药物。 该产品能很好地掩盖药物的异味，并在口服时提供良好的感觉，因此即使是老人、儿童和吞咽困难患者也很容易摄入。 此外，该产品还适合使用软管给药。
• PHARMACEUTICAL COMPOSITION
  申请人：NAKAGAMI Hiroaki

  公开号：US20070148235A1

  公开（公告）日：2007-06-28

  The present invention relates to a granular pharmaceutical composition comprising a drug having a disagreeable taste, a wax and a sugar alcohol; a method for preparing the same; and a pharmaceutical product for oral administration, comprising the granular composition. The product excellently masks a disagreeable taste possessed by a drug and provides good sensation upon oral administration, and therefore is easily ingested by even the elderly, children, and patients suffering dysphagia. Moreover, the product is suitable for administration using tube.